https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01787-1/fulltext
0
0
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial - The Lancet
+ 72 more
9/18/22 at 3:36pm
Organization
The Lancet
Authors
Details
67 words
Summarize
Heart & Hypertension Business & Industrial Medical Facilities & Services renal artery denervation follow-up SYMPLICITY HTN-3 HTN-3 Trial - The Lancet artery denervation
This final report of the SYMPLICITY HTN-3 trial adds to the totality of evidence supporting the safety of renal artery denervation to 36 months after the procedure. From 12 months to 36 months after the procedure, patients who were originally randomly assigne…
Create an account or login to join the discussion